Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cilazapril adverse reaction |
Causative agent |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
allergi over for cilazapril |
Causative agent |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
|
Product containing cilazapril (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cilazapril 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
|
Cilazapril 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
|
Cilazapril 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
|
Cilazapril 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
|
Non-allergic hypersensitivity to cilazapril (finding) |
Causative agent |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
|
Non-allergic hypersensitivity to cilazapril (finding) |
Causative agent |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Non-allergic hypersensitivity to cilazapril (finding) |
Causative agent |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
2 |
Cilazapril monohydrate (substance) |
Is a |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
|
Product containing precisely cilazapril 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cilazapril 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Cilazapril 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Cilazapril 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Cilazapril 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Cilazapril 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Cilazapril 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Cilazapril 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cilazapril 500 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Cilazapril 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Cilazapril 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Cilazapril 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Product containing cilazapril in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Cilazapril monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
|
Product containing only cilazapril (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Product containing only cilazapril in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cilazapril (as cilazapril monohydrate) 1 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cilazapril (as cilazapril monohydrate) 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cilazapril (substance) |
Inferred relationship |
Some |
1 |
Cilazapril anhydrous |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cilazapril (substance) |
Inferred relationship |
Some |
|